This open enrollment, choose a plan that includes access to our world-class providers. Get better care now

Menu
Search

UCSD Professor Named President of American Society of Gene Therapy

 

June 27, 2006  |  

Theodore Friedmann also honored as distinguished graduate of the University of Pennsylvania

Theodore Friedmann, M.D., Professor of Pediatrics and Director of the Center for Molecular Genetics at UCSD School of Medicine, has been named president of the American Society of Gene Therapy. He will preside over the next annual meeting of the ASGT, being held in Seattle in June 2007. 

Theodore Friedmann, MDFriedmann has been a leader in the field of gene-based therapies for over more than three decades. He is widely credited for helping to bring the potential of this field to the forefront when he wrote a seminal paper called "Gene Therapy for Human Genetic Disease?" that appeared in the journal Science in 1972.





Theodore Friedmann, M.D.

The ASGT, founded in 1996 is a professional non-profit medical and scientific organization with almost 3,000 members. ASGT is the largest medical professional organization representing researchers and scientists dedicated to discovering new gene therapies. Its official journal, Molecular Therapy, which publishes scientific papers in the areas of gene transfer, regulation and discovery, cell therapy, experimental models, correction of genetic and acquired diseases, and clinical trials.

Friedmann was also recently honored with a 2006 Distinguished Graduate Award from the University of Pennsylvania, where he earned his medical degree. John Reed, M.D., President of the Burnham Institute, is a fellow 2006 recipient of this award, and UCSD Vice Chancellor of Health Sciences, Edward W. Holmes, M.D., received this distinction in 2001.

"Dr. Friedmann has been a leading player in gene therapy for more than 30 years. He was one of the writers of what is considered a ‘founding statement’ on the field. As both an advocate and critic of gene therapy, he has asserted, ‘Medicine needs this technology. It’s not just a choice.’ We are just as certain that medicine needs people of science of Ted Friedmann’s caliber, and are proud to name him one of our Distinguished Graduates," said Arthur H. Rubenstein, MBBCh, Vice President for the Health System and Dean for the School of Medicine at the University of Pennsylvania.

Friedmann’s expertise and research interests are in the development of model systems for human gene therapy, with techniques including gene isolation and characterization, constructions of viral vectors and in-vivo replacement of genetically altered cells. He received UCSD’s Faculty Research Lecturer Award in 1984-85; a University of California, Chancellor’s Associates Award for Excellence in Research, 1992; the H.C. Jacobæus Prize of the Nordic Research Committee and Nordic Insulin Foundation, Lund, Sweden, 1995; Cross of Honor for Science and the Arts, Republic of Austria, 1996; among other awards and honors.

# # #

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu

UCSD Health Sciences Communications HealthBeat: News

 


Related Services

Genetic Services



Media Contact

Share This Article


Related News

11/14/2019
Researchers identified non-coding regions of the human genome that control the development and function of four brain cell types and mapped genetic risk variants for psychiatric diseases. They found t ...
11/13/2019
Researchers at University of California San Diego School of Medicine, as well as a diverse team of cardiologists and physicists, developed a machine learning algorithm to predict the life expectancy i ...
11/13/2019
UC San Diego researchers linked a gut bacteria toxin to worse clinical outcomes in patients with alcoholic liver disease, and discovered that treatment with bacteriophages clears the bacteria and elim ...
11/12/2019
National attention has been drawn to the plight of patients who have experienced the unintended side effects of prolonged ICU care such as memory loss and muscle weakness. Now, a research team led by ...



Follow Us